rs9716700
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001204375.2(NPR3):c.-250C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.175 in 1,199,638 control chromosomes in the GnomAD database, including 20,208 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1745 hom., cov: 30)
Exomes 𝑓: 0.18 ( 18463 hom. )
Consequence
NPR3
NM_001204375.2 5_prime_UTR
NM_001204375.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.685
Genes affected
NPR3 (HGNC:7945): (natriuretic peptide receptor 3) This gene encodes one of three natriuretic peptide receptors. Natriutetic peptides are small peptides which regulate blood volume and pressure, pulmonary hypertension, and cardiac function as well as some metabolic and growth processes. The product of this gene encodes a natriuretic peptide receptor responsible for clearing circulating and extracellular natriuretic peptides through endocytosis of the receptor. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 5-32711527-C-A is Benign according to our data. Variant chr5-32711527-C-A is described in ClinVar as [Benign]. Clinvar id is 1177755.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPR3 | NM_001204375.2 | c.-250C>A | 5_prime_UTR_variant | 1/8 | ENST00000265074.13 | NP_001191304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPR3 | ENST00000265074 | c.-250C>A | 5_prime_UTR_variant | 1/8 | 1 | NM_001204375.2 | ENSP00000265074.8 |
Frequencies
GnomAD3 genomes AF: 0.134 AC: 20022AN: 149838Hom.: 1745 Cov.: 30
GnomAD3 genomes
AF:
AC:
20022
AN:
149838
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.181 AC: 190449AN: 1049700Hom.: 18463 Cov.: 20 AF XY: 0.181 AC XY: 89675AN XY: 494978
GnomAD4 exome
AF:
AC:
190449
AN:
1049700
Hom.:
Cov.:
20
AF XY:
AC XY:
89675
AN XY:
494978
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.133 AC: 20009AN: 149938Hom.: 1745 Cov.: 30 AF XY: 0.131 AC XY: 9564AN XY: 73074
GnomAD4 genome
AF:
AC:
20009
AN:
149938
Hom.:
Cov.:
30
AF XY:
AC XY:
9564
AN XY:
73074
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
102
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2021 | This variant is associated with the following publications: (PMID: 10489108) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at